Location: Home
  • search
  • go
  • Relate News
  • 9/7/2018NMPA Withdraws Approvals of Six Drugs Including Four Import Drugs
  • 9/6/2018Eisai and MSD Announce NMPA Approval of HCC Drug LENVIMA
  • 9/5/2018NMPA Approves Alexion's Orphan Drug Soliris (Eculizumab)
  • 9/5/2018Chi-Med Announces Chinese Approval of CRC Drug Fruquintinib
  • 9/5/2018Minomic Secures Key Patent in the U.S. and China
  • 9/4/2018IQVIA: Chinese Hospital Drug Market Up 3.7% in MAT Q1/2018
  • 9/3/2018Listed Chinese Healthcare Cos Witness Best Performance in Nine Years
  • 8/31/2018Recent Executive Moves
  • 8/31/2018Financial-related Company News in Brief
  • 8/30/2018Final Government Reorganization Plan Unveils Regulatory Roles of SAMR ...
  • 8/30/2018New English Name of China's Drug Watchdog Confirmed to be NMPA
  • 8/30/2018NYT: China Withholds H7N9 Bird Flu Sample
  • 8/29/2018State Council Issues Notice for Major Tasks of Healthcare Reform in H2...
  • 8/29/2018CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China
  • 8/29/2018Bloomburg: Wall Street Expats Angle for Piece of China’s Biotech Drug...
  • 8/28/2018Premier Li Keqiang Orders Reinforced Healthcare Reform
  • 8/28/2018I-Mab Approved to Initiate Clinical Study of Genexine’s Diabetes Drug
  • 8/28/2018China Biologic Turns Down Buyout Proposal from CEO-led Consortium
  • 8/27/2018Harbour BioMed Raises $85M in Series B Financing to Accelerate Its Inn...
  • 8/27/2018FT: China Health Reforms Help Global Pharma Groups Despite Price Cuts?
  • 8/24/2018Recent Executive Moves
  • 8/24/2018CDH-backed Mabpharm Files for Hong Kong IPO
  • 8/22/2018Chinese VC GL Capital Buys 5% Stake in Oxford Biodynamics
  • 8/22/2018USFDA Recalls Thyroid Drugs Containing Chinese API over GMP and Qualit...
  • 8/21/2018BMS's Opdivo To Be Priced in China at Half Cost in the U.S.
  • 8/21/2018The Impact of Scientific Data Administrative Measures on Foreign Compa...
  • 8/21/2018Fitch: Healthcare Reforms in China Present Upside Potential amid Indus...
  • 8/20/2018Harbour BioMed Licenses Ex-China Rights of PD-L1 Inhibitor from Sichua...
  • 8/20/2018Bio-Thera Announces CNDA Acceptance of Biologics Application for Humir...
  • 8/20/2018SMIA Announces Scope of BMI Anticancer Reimbursement Negotiation
  • Page:133/334 Total number of articles:9998: [First][<<] [131] [132] [133] [134] [135] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group